The prognostic value of CD105 and CD31 has been assessed earlier in breast, colon and ovarian carcinomas (Dales et al, 2004; Erdem et al, 2006; Minhajat et al, 2006; Dhakal et al, 2008). This evidence concerns the gene ENG and ovarian carcinoma.